Luc Tanguay - Theratechnologies President, Chief Executive Officer, Director
TH Stock | CAD 1.80 0.05 2.70% |
CEO
Mr. Luc Tanguay is President, Chief Executive Officer, Director of Theratechnologies, Inc. Mr. Tanguay was active in the biotechnology industry for over 20 years. As a member of our senior management since 1996, he has contributed to our growth by facilitating access to public and private capital funding. A member of the board of directors since 1993, he has held various management positions since joining the Company. Prior to joining us, Mr. Tanguay had a career in investment banking at National Bank Financial Inc. Mr. Tanguay obtained his M. Sc. Finance from the University of Sherbrooke. since 2014.
Age | 57 |
Tenure | 10 years |
Address | 2015 Peel Street, Montreal, QC, Canada, H3A 1T8 |
Phone | 514 336 7800 |
Web | https://www.theratech.com |
Theratechnologies Management Efficiency
The company has return on total asset (ROA) of (0.0455) % which means that it has lost $0.0455 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (11.1686) %, meaning that it generated substantial loss on money invested by shareholders. Theratechnologies' management efficiency ratios could be used to measure how well Theratechnologies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of April 2024, Return On Equity is likely to grow to 1.39, while Return On Tangible Assets are likely to drop (0.44). At this time, Theratechnologies' Non Current Assets Total are very stable compared to the past year. As of the 26th of April 2024, Other Current Assets is likely to grow to about 10 M, while Total Assets are likely to drop about 65.2 M.Similar Executives
Found 4 records | CEO Age | ||
Michael Sifton | Data Communications Management | 56 | |
Marcel Hilmer | Forsys Metals Corp | N/A | |
Michael England | Arbor Metals Corp | 52 | |
Richard Kellam | Data Communications Management | 58 |
Management Performance
Return On Equity | -11.17 | ||||
Return On Asset | -0.0455 |
Theratechnologies Leadership Team
Elected by the shareholders, the Theratechnologies' board of directors comprises two types of representatives: Theratechnologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Theratechnologies. The board's role is to monitor Theratechnologies' management team and ensure that shareholders' interests are well served. Theratechnologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Theratechnologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
MarieNoel Colussi, Vice President - Finance | ||
Luc Tanguay, President, Chief Executive Officer, Director | ||
Jovan Antunovic, Senior Vice President and Chief Commercial Office | ||
Conor Walshe, General Manager - Theratechnologies Europe Limited | ||
Sheila Frame, Independent Director | ||
Paul Lvesque, CEO President | ||
Philippe Dubuc, Chief Financial Officer, Senior Vice President | ||
Paul Levesque, President, Chief Executive Officer, Director | ||
Andrew Molson, Independent Director | ||
Gerald Lacoste, Independent Director | ||
LLB LLM, General Secretary | ||
Dawn Svoronos, Independent Chairman of the Board | ||
Pierre Perazzelli, Vice President - Pharmaceutical Development | ||
LLB BA, VP Affairs | ||
Denis Boucher, Vice President - Communications and Corporate Affairs | ||
H MSc, Vice Resources | ||
Chantal Placais, Executive Assistant | ||
Lyne Fortin, Senior Vice President Chief Commercial Officer | ||
Christian Marsolais, Senior Vice President - Scientific Affairs and Alliances | ||
John Leasure, Global Officer | ||
Paul Pommier, Independent Director | ||
Gilles Cloutier, Independent Director | ||
Gary Littlejohn, Independent Director | ||
JeanDenis Talon, Independent Director | ||
Elif McDonald, Director Relations | ||
Jocelyn Lafond, Vice President - Legal Affairs, Corporate Secretary | ||
Alain Trudeau, Independent Director | ||
MBA MBA, Senior CFO | ||
Dale Weil, Independent Director |
Theratechnologies Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Theratechnologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -11.17 | ||||
Return On Asset | -0.0455 | ||||
Profit Margin | (0.23) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 105.75 M | ||||
Shares Outstanding | 45.98 M | ||||
Shares Owned By Insiders | 6.28 % | ||||
Shares Owned By Institutions | 50.73 % | ||||
Number Of Shares Shorted | 22.73 K | ||||
Price To Earning | (52.28) X |
Currently Active Assets on Macroaxis
When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Theratechnologies Stock analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |